| Record ID | marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:495035057:1305 |
| Source | Western Washington University |
| Download Link | /show-records/marc_western_washington_univ/wwu_bibs.mrc_revrev.mrc:495035057:1305?format=raw |
LEADER: 01305cam 2200301 a 4500
001 ocm07723672
008 810901s1981 dcua b f00010 eng d
035 $a(GPO)81012369
040 $aGPO$cGPO$dMvI
049 $aXFFA
086 0 $aY 3.T 22/2:2 C 82/no.2/case 7
100 10 $aLuce, Bryan R
245 10 $aAllocating costs and benefits in disease prevention programs :$ban application to cervical cancer screening /$cBryan R. Luce
260 0 $aWashington, D.C. :$bCongress of the United States, Office of Technology Assessment :$bFor sale by the Supt. of Docs., U.S. G.P.O.,$c1981
300 $aviii, 31 p. :$bill. ;$c26 cm
440 4 $aThe implications of cost-effectiveness analysis of medical technology.$nBackground paper #2,$pCase studies of medical technologies ;$vcase study #7
500 $a"June 1981."
504 $aBibliography: p. 30-31
500 $a"OTA-BP-H-9(7)"--P. 4 of cover
650 0 $aCervix uteri$xCancer$xDiagnosis
650 0 $aMedicine, Preventive$xCost effectiveness
650 0 $aMedical technology$xCost effectiveness
650 0 $aMedical instruments and apparatus$xCost effectiveness
710 10 $aUnited States.$bCongress.$bOffice of Technology Assessment
907 $a.b16598891$bmulti$c-
902 $a071013
998 $b1$c970812$dm$ea$f-$g0
902 $aMarcive